Symbol="RYTM"
AssetType="Common Stock"
Name="Rhythm Pharmaceuticals Inc"
Description="Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of rare genetic diseases of obesity. The company is headquartered in Boston, Massachusetts."
CIK="1649904"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1520300000"
EBITDA="-178714000"
PERatio="None"
PEGRatio="None"
BookValue="3.204"
DividendPerShare="0"
DividendYield="0"
EPS="-3.38"
RevenuePerShareTTM="0.791"
ProfitMargin="0"
OperatingMarginTTM="-4.124"
ReturnOnAssetsTTM="-0.384"
ReturnOnEquityTTM="-0.964"
RevenueTTM="43765000"
GrossProfitTTM="21505000"
DilutedEPSTTM="-3.38"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.12"
AnalystTargetPrice="38.22"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="95.69"
PriceToBookRatio="5.01"
EVToRevenue="63.85"
EVToEBITDA="-3.718"
Beta="1.686"
num_52WeekHigh="34.99"
num_52WeekLow="15.5"
num_50DayMovingAverage="18.47"
num_200DayMovingAverage="22.37"
SharesOutstanding="56855000"
DividendDate="None"
ExDividendDate="None"
symbol="RYTM"
open="26.62"
high="27.15"
low="26.34"
price="26.63"
volume="629541.00"
latest_trading_day="2023-08-11"
previous_close="26.74"
change="-0.11"
change_percent="-0.4114%"
aroon_positive_momentum_days="9"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="9"
Volume_recent_avg="746031"
Change_recent_avg="0.08"
Delta_recent_avg="0.97"
Variance_recent_avg="0.49"
Change_ratio_recent_avg="0.27"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="9"
Aroon_momentum_negative="91"
image_negative_thumbnail_id_1="153"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0023.jpeg"
image_negative_thumbnail_id_2="1101"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0134.jpeg"
image_neutral_thumbnail_id_1="577"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0022.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="954"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0116.jpeg"
image_positive_thumbnail_id_2="663"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
